Mitsui & Co. and two of its U.S. subsidiaries have agreed to pay a combined $53 million (about 5.8 billion yen) to settle a class-action lawsuit in the United States over suspected vitamin price-fixing, Mitsui said Tuesday.
The two Mitsui subsidiaries are Mitsui & Co. (U.S.A.) in New York and Ohio-based Bioproducts Inc. Mitsui & Co., Bioproducts and two non-Mitsui group firms were ordered in June to pay a total of $49 million in damages. The case was filed by consumers at the U.S. District Court for the District of Columbia.
The four firms plotted to fix the price of vitamin B-4, used as an animal feed supplement, between 1988 and 1998, the plaintiffs said.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.